IN8BIO, INC. — Director's Dealing 2023

Jun 24, 2023

SEC Form 4/A — Form 4/A

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-04-14

Reporting Person: Ho William Tai-Wei (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-14	Employee Stock Option (right to buy)	$1.21	A	393950	Acquired	2033-04-14	Common Stock (393950)	Direct

Footnotes

F1: The initial Form 4 inadvertently listed the wrong exercise price and expiration date. This amendment reflects the revised exercise price and expiration date for this option.

F2: Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.